Health Care · Health Care Supplies
West Pharmaceutical Services: revenue, profit and dividends
In fiscal 2025, West Pharmaceutical Services had revenue of $3.07B, up 8.2% a year on average since 2015, and net income of $494M (16.1% of revenue). Its dividend per share has gone up 17 years in a row, to $0.86.
Revenue, fiscal 2025
average annual revenue growth since 2015 · +6.3% vs 2024
- Ticker
- WST · NYSE
- Sector
- Health Care
- Sub-industry
- Health Care Supplies
- Headquarters
- Exton, Pennsylvania
- Founded
- 1923
- In the S&P 500 since
- May 22, 2020
- Latest fiscal year
- 2025, ended December 31, 2025
- SEC filer
- West Pharmaceutical Services Inc · CIK 0000105770
Revenue and net income
Revenue went from $1.05B in 2008 to $3.07B in 2025.
Diluted earnings per share
Diluted EPS went from $1.25 in 2008 to $6.79 in 2025. Ten-year growth: 18.0% a year.
Dividends per share
Raised every year in the data: 17 years in a row, from 2009 to 2025. Ten-year growth: 6.5% a year.
Shares outstanding
1.5% fewer shares in 2025 than in 2015 (73.8M → 72.7M): buybacks outweighed new shares.
Operating cash flow, capex and free cash flow
Free cash flow (operating cash flow minus capital expenditure) was $469M in 2025, 15.3% of revenue. Negative in 2008.
The chart data could not be loaded. The table below has the same figures.
Year by year
| Fiscal year | Revenue | Net income | Net margin | Diluted EPS | Dividend | Shares | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $3.07B | $494M | 16.1% | $6.79 | $0.86 | 72.7M | $755M | $286M | $469M |
| 2024 | $2.89B | $493M | 17.0% | $6.69 | $0.82 | 73.7M | $653M | $377M | $276M |
| 2023 | $2.95B | $593M | 20.1% | $7.88 | $0.78 | 75.3M | $776M | $362M | $414M |
| 2022 | $2.89B | $586M | 20.3% | $7.73 | $0.74 | 75.8M | $724M | $285M | $439M |
| 2021 | $2.83B | $662M | 23.4% | $8.67 | $0.70 | 76.3M | $584M | $253M | $331M |
| 2020 | $2.15B | $346M | 16.1% | $4.57 | $0.66 | 75.8M | $472M | $174M | $298M |
| 2019 | $1.84B | $242M | 13.1% | $3.21 | $0.62 | 75.4M | $367M | $126M | $241M |
| 2018 | $1.72B | $207M | 12.0% | $2.74 | $0.58 | 75.4M | $289M | $105M | $184M |
| 2017 | $1.6B | $151M | 9.4% | $1.99 | $0.54 | 75.8M | $263M | $131M | $132M |
| 2016 | $1.51B | $144M | 9.5% | $1.91 | $0.50 | 75M | $219M | $170M | $49.2M |
| 2015 | $1.4B | $95.6M | 6.8% | $1.30 | $0.46 | 73.8M | $212M | $132M | $80.8M |
| 2014 | $1.42B | $127M | 8.9% | $1.75 | $0.41 | 72.8M | $183M | $112M | $71M |
| 2013 | $1.37B | $112M | 8.2% | $1.57 | $0.39 | 71.4M | $220M | $152M | $68.6M |
| 2012 | $1.27B | $80.7M | 6.4% | $1.15 | $0.37 | 71.8M | $187M | $131M | $56.1M |
| 2011 | $1.19B | $75.5M | 6.3% | $1.08 | $0.35 | 74M | $131M | $95.4M | $35.3M |
| 2010 | $1.1B | $65.3M | 5.9% | $0.94 | $0.33 | 73.4M | $138M | $71.1M | $67.2M |
| 2009 | $1.06B | $72.6M | 6.9% | $1.06 | $0.31 | 72.6M | $138M | $105M | $32.8M |
| 2008 | $1.05B | $86M | 8.2% | $1.25 | $0.29 | 72.2M | $135M | $139M | −$3.6M |
Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data.
Stock splits
Found in the filings; per-share figures and share counts on this page are on today’s share basis.
- 2-for-1 split · first reflected in a filing of November 4, 2013
About these figures
- Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.
Other Health Care Supplies companies
Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.